Navigation Links
NexBio to Present at 2007 BIOCOM Investor Conference
Date:10/31/2007

SAN DIEGO, Oct. 31 /PRNewswire/ -- NexBio, Inc. a privately held development-stage biopharmaceutical company located in San Diego, announced today that Dr. David Wurtman, its Vice President of Corporate Development, will present a corporate overview and update at the BIOCOM Investor Conference on November 1, 2007.

NexBio's mission is to save lives, and to improve the quality of life, by creating and commercializing novel, broad-spectrum biopharmaceuticals to prevent and treat current and emerging life-threatening human viral respiratory diseases. NexBio has received significant financial support through grants and contracts from the National Institutes of Health for development of Fludase(TM), its lead program, a first-in-class broad-spectrum prophylactic and therapeutic agent to potentially address all annual and pandemic variations of influenza, including the Avian IFV H5N1 ("Bird Flu"), as well as parainfluenza. Product candidates in NexBio's pipeline may address additional viral infections, such as RSV.

The company also possesses TOSAP(TM), a novel, elegant, flexible & scalable formulation technology, invented by NexBio scientists, which it uses to make dry-powder microspheres to allow drugs to be delivered by inhalation. TOSAP(TM) is being applied to expand the company's pipeline, and is also being licensed to partners who wish to formulate their own compounds.

NexBio is actively seeking corporate partnerships from companies that have extensive experience in late stage drug development and commercialization, as well as entertaining inquiries from financing sources that may wish to invest in the company.

For more information about NexBio, Inc., please visit http://www.nexbio.com

Contact:

David Wurtman, M.D., M.B.A

VP, Corporate Development

10665 Sorrento Valley Road

San Diego, CA 92121

Phone: (858) 452-2631

dwurtman@nexbio.com

Note: FDA has yet to approve the name Fludase.


'/>"/>
SOURCE NexBio, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: